Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Hakushindo Pharmaceutical Co., Ltd." found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Hakushindo Pharmaceutical Co., Ltd. for you to read. Along with our medical data and news we also list Hakushindo Pharmaceutical Co., Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hakushindo Pharmaceutical Co., Ltd. Companies for you to search.
IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019. Marking their 26th year, the Awards highlight Cambridge’s best business talent, with winners selected by a panel of experts encompassing a broad ra...
LUND, Sweden, 25 March 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now availabl...
Exscientia K.K will spearhead the company's pharmaceutical interests across Asia
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
Improving regulatory procedures to encourage innovation In 2017, the Chinese Food and Drugs Administration (CFDA) announced a series of policies...Read More... The post How government policy has shaped China’s pharma phenomenon appeared first on Pharmaceutical Technology.
Sartan recalls continue as Legacy Pharmaceutical Packaging recalls 40 lots of losartan tablets at the consumer level.
“Today’s submission brings us one step closer to our goal of improving treatment outcomes for people newly diagnosed with multiple myeloma,” said José Antonio Burón Vidal, VP Medical The post Janssen seeks expanded use of Darzalex combination therapy for patients with newly diagnosed ASCT multiple myeloma appeared first on Pharmaceutical Business review.
“Today’s submission brings us one step closer to our goal of improving treatment outcomes for people newly diagnosed with multiple myeloma,” said José Antonio Burón Vidal, VP Medical The post Janssen seeks expanded use of Darzalex combination therapy for patients with newly diagnosed multiple myeloma appeared first on Pharmaceutical Business review.
Proceeds to build pipeline of novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain Synerkine Pharma B.V., which develops fusion proteins for the treatment of chronic pain, announced today that it successfully closed a EUR 3.3 million Series A financing from Thuja Capital, an undisclosed private investor, and the ...
Owned by Ampersand Capital Partners, Brammer Bio is engaged in the clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy. The post Thermo Fisher Scientific to buy viral vector CDMO Brammer Bio for $1.7bn appeared first on Pharmaceutical Business review.
HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall. Under the terms of the ag...
Gov. Roy Cooper, Secretary of Commerce Tony Copeland and local patient advocates will join chief bluebird Nick Leschly in a ribbon cutting ceremony at the 125,000-square-foot facility. Currently, The post bluebird bio opens gene and cell therapy manufacturing facility in North Carolina appeared first on Pharmaceutical Business review.
This chart shows the drugs with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Germany... The post Which pharmaceutical drugs have the most drug patents in Germany? appeared first on Biotechblog.
Janssen Pharmaceutica has filed an application with the European Medicines Agency (EMA) for expanded indication of Darzalex (daratumumab) to treat...Read More... The post Janssen seeks approval for new applications of multiple myeloma drug appeared first on Pharmaceutical Technology.
Thermo Fisher Scientific has signed a definitive agreement to acquire viral vector manufacturing company Brammer Bio for a cash consideration...Read More... The post Thermo Fisher to buy Brammer Bio for $1.7bn appeared first on Pharmaceutical Technology.
A new study conducted by the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine has...Read More... The post Study finds new drug combo could treat paediatric brain tumour appeared first on Pharmaceutical Technology.
(Goethe University Frankfurt) Bacteria produce a cocktail of various bioactive natural products in order to survive in hostile environments with competing (micro)organisms. In the current issue of Nature Chemical Biology, researchers at Goethe University demonstrate that they do so by modifying basic structures, similar to the approach taken in pharmaceutical research.
Uppsala, Sweden, March 25, 2019 – Oasmia Pharmaceutical AB (NASDAQ: OASM) today announce that the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a type II variation application to add efficacy data to the Apealea product information. The marketing authorisation approval for Apealea in the EEA was based on the phase III pivotal study OAS‑07OVA. The st...
There is no better place to watch science in action than in the world of medicine. It was discovered in the 1930s that blood, in the presence of a certain streptococcus bacteria, did not clot. The agent formed by the bacteria was isolated and eventually called streptokinase, the first “clot-buster.” Through the decades, pharmaceutical companies […] Find jobs at Careers by KevinM...
This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their… The post Pharmaceutical companies with the most ‘P... The post Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs appeared first on Biotechblog.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in ...
Walgreens is supporting relief efforts in Iowa and Nebraska as communities across the region continue to recover from record flooding. Walgreens is donating $25,000 to the American Red Cross relief efforts, and many of its stores have provided donations of over-the-counter medications and medical supplies to various community partners. Be...
It is unlikely that figures on NHS England prescriptions for medical cannabis will be published by the end of March 2019, despite ministerial assurances that they would, The Pharmaceutical Journal has been told.
22 March 2019 – Pharmaceutical companies Biogen and Eisai have announced the discontinuation of two Phase 3 trials of aducanumab. The decision came after analysis by an independent monitoring committee indicated the trials were unlikely to succeed. Biogen and Eisai will continue to investigate other treatments for Alzheimer’s disease, including anti-amyloid treatment BAN2401....
NHS England spin-out Genomics England and artificial intelligence (AI)-focused Cambridge Cancer Genomics (CCG) have announced they have entered into an...Read More... The post Genomics England signs immunotherapy partnership with CCG appeared first on Pharmaceutical Technology.